159 related articles for article (PubMed ID: 17426086)
21. Review of studies of androgen treatment of female-to-male transsexuals: effects and risks of administration of androgens to females.
Gooren LJG; Giltay EJ
J Sex Med; 2008 Apr; 5(4):765-776. PubMed ID: 17971101
[TBL] [Abstract][Full Text] [Related]
22. Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study.
Puurunen J; Piltonen T; Puukka K; Ruokonen A; Savolainen MJ; Bloigu R; Morin-Papunen L; Tapanainen JS
J Clin Endocrinol Metab; 2013 Dec; 98(12):4798-807. PubMed ID: 24152688
[TBL] [Abstract][Full Text] [Related]
23. Testosterone addition to estrogen therapy - effects on inflammatory markers for cardiovascular disease.
Kocoska-Maras L; Hirschberg AL; Byström B; Schoultz BV; Rådestad AF
Gynecol Endocrinol; 2009 Dec; 25(12):823-7. PubMed ID: 19906002
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
25. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
26. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
[TBL] [Abstract][Full Text] [Related]
27. Testosterone supplementation: why and for whom?
Gooren L
Aging Male; 2003 Sep; 6(3):184-99. PubMed ID: 14628499
[TBL] [Abstract][Full Text] [Related]
28. Central hypothyroidism and its replacement have a significant influence on cardiovascular risk factors in adult hypopituitary patients.
Klose M; Marina D; Hartoft-Nielsen ML; Klefter O; Gavan V; Hilsted L; Rasmussen AK; Feldt-Rasmussen U
J Clin Endocrinol Metab; 2013 Sep; 98(9):3802-10. PubMed ID: 23796569
[TBL] [Abstract][Full Text] [Related]
29. Discontinuing long-term GH replacement therapy--a randomized, placebo-controlled crossover trial in adult GH deficiency.
Filipsson Nyström H; Barbosa EJ; Nilsson AG; Norrman LL; Ragnarsson O; Johannsson G
J Clin Endocrinol Metab; 2012 Sep; 97(9):3185-95. PubMed ID: 22791760
[TBL] [Abstract][Full Text] [Related]
30. Association between circulating endogenous androgens and insulin sensitivity changes with exercise training in midlife women.
Krishnan S; Gustafson MB; Campbell C; Gaikwad NW; Keim NL
Menopause; 2014 Sep; 21(9):967-74. PubMed ID: 24496084
[TBL] [Abstract][Full Text] [Related]
31. The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance.
Beshyah SA; Henderson A; Niththyananthan R; Skinner E; Anyaoku V; Richmond W; Sharp P; Johnston DG
J Clin Endocrinol Metab; 1995 Feb; 80(2):356-63. PubMed ID: 7852490
[TBL] [Abstract][Full Text] [Related]
32. Replacement therapy and cardiovascular diseases.
Boschetti M; Goglia U; Teti C; Esposito D; Giusti M; Minuto F; Ferone D
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):85-90. PubMed ID: 19020394
[TBL] [Abstract][Full Text] [Related]
33. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
34. The differential effect of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women: relationship with the metabolic status.
Villa P; Costantini B; Suriano R; Perri C; Macrì F; Ricciardi L; Panunzi S; Lanzone A
J Clin Endocrinol Metab; 2009 Feb; 94(2):552-8. PubMed ID: 19017760
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH--an update.
Gazzaruso C; Gola M; Karamouzis I; Giubbini R; Giustina A
J Clin Endocrinol Metab; 2014 Jan; 99(1):18-29. PubMed ID: 24217903
[TBL] [Abstract][Full Text] [Related]
36. Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system.
Jones TH; Kelly DM
Asian J Androl; 2018; 20(2):120-130. PubMed ID: 29442075
[TBL] [Abstract][Full Text] [Related]
37. Androgen replacement for women.
Basson R
Can Fam Physician; 1999 Sep; 45():2100-7. PubMed ID: 10509222
[TBL] [Abstract][Full Text] [Related]
38. A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder.
White WB; Grady D; Giudice LC; Berry SM; Zborowski J; Snabes MC
Am Heart J; 2012 Jan; 163(1):27-32. PubMed ID: 22172433
[TBL] [Abstract][Full Text] [Related]
39. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.
Lovejoy JC; Bray GA; Greeson CS; Klemperer M; Morris J; Partington C; Tulley R
Int J Obes Relat Metab Disord; 1995 Sep; 19(9):614-24. PubMed ID: 8574271
[TBL] [Abstract][Full Text] [Related]
40. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome.
Chu MC; Cosper P; Nakhuda GS; Lobo RA
Fertil Steril; 2006 Dec; 86(6):1669-75. PubMed ID: 17074346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
